| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/29/2002 | EP1207895A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 05/29/2002 | EP1207892A1 Use of oyster flesh enzymatic hydrolysates for preparing compositions eliminating free radicals |
| 05/29/2002 | EP1207885A1 Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract |
| 05/29/2002 | EP1207884A2 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes |
| 05/29/2002 | EP1207877A1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids |
| 05/29/2002 | EP1207876A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 05/29/2002 | EP1207873A1 Methods of inhibiting osteoclast activity |
| 05/29/2002 | EP1207859A1 Oral form of administration containing probiotic micro-organisms |
| 05/29/2002 | EP1207853A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 05/29/2002 | EP0938329B1 Immunogenic tlp composition |
| 05/29/2002 | EP0923382B1 Compositions of plant carbohydrates as dietary supplements |
| 05/29/2002 | EP0752002B1 Inhibition of arterial smooth muscle cell proliferation |
| 05/29/2002 | EP0573544B1 Intestinal trefoil proteins |
| 05/29/2002 | EP0300021B2 A process for treating infertility and an agent for use in the process |
| 05/29/2002 | DE10059053A1 Anticoagulant composition containing anticoagulant in acidic solution or suspension useful e.g. for treatment of thrombosis and for promotion of wound healing |
| 05/29/2002 | DE10058319A1 Verfahren zur Selektion von Peptid-Liganden A method for the selection of peptide ligands |
| 05/29/2002 | DE10057871A1 Production of milk hydrolysate used for improving psychic health comprises especially hydrolysis of milk powder or casein with pepsin |
| 05/29/2002 | DE10055742A1 Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen New polyester, process for their preparation and depot dosage forms prepared from the polyesters |
| 05/29/2002 | CN1351714A Tandem immuno-assay for cancer |
| 05/29/2002 | CN1351666A Recombinant bacterial phytases and uses thereof |
| 05/29/2002 | CN1351664A DNA sequence and recombination production of a graminae allergen |
| 05/29/2002 | CN1351661A Compounds |
| 05/29/2002 | CN1351613A Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity |
| 05/29/2002 | CN1351611A Long lasting fusion peptide inhibitors of viral infection |
| 05/29/2002 | CN1351610A Formation and anion-exchange of crystalline echinocandin ammonium salts |
| 05/29/2002 | CN1351609A Low-molecular inhibitors of complement proteases |
| 05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
| 05/29/2002 | CN1351587A Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 05/29/2002 | CN1351496A Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
| 05/29/2002 | CN1351174A Inhibiting material for inverting enzyme for angiotensin I |
| 05/29/2002 | CN1351167A Polypeptide-human protein 9.35 containing dihydroorotase characteristic sequence fragment and polynucleotide for coding it |
| 05/29/2002 | CN1351166A Polypeptide-human ubiquitin-specific protease 47.19 and polynucleotide for coding it |
| 05/29/2002 | CN1351165A Polypeptide-human matrical metalloprotease 15.29 and polynucleotide for coding it |
| 05/29/2002 | CN1351164A Polypeptide-signal peptidase 9.68 and polynucleotide for coding it |
| 05/29/2002 | CN1351163A Polypeptide-human protein tyrosine phosphorylase 10.01 and polynucleotide for coding it |
| 05/29/2002 | CN1351162A Polypeptide-ribonuclease P4030.69 and polynucleotide for coding it |
| 05/29/2002 | CN1351161A Polypeptide-human calcineurin 811.55 and polynucleotide for coding it |
| 05/29/2002 | CN1351160A Polypeptide-Na-K adenosine triphosphatase beta subunit 10.01 and polynucleotide for coding it |
| 05/29/2002 | CN1351159A Polypeptide-human RNA uncoiling enzyme 17.49 and polynucleotide for coding it |
| 05/29/2002 | CN1351158A Polypeptide-Ser/Thr protein kinase 25.96 and polynucleotide for coding it |
| 05/29/2002 | CN1351157A Polypeptide-human focal adhesion kinase 9.9 and polynucleotide for coding it |
| 05/29/2002 | CN1351156A Polypeptide-prolylgomeric peptidase 8.8 and polynucleotide for coding it |
| 05/29/2002 | CN1351155A Polypeptide-Ser/Thr specific protein kinase 41.14 anjd polynucleotide for coding it |
| 05/29/2002 | CN1351154A Polypeptide-human eukaryotic actyltransferase 11.44 and polynucleotide for coding it |
| 05/29/2002 | CN1351153A Polypeptide-human methylated-DNA-protein-system acid methyltransferase 16.39 and polynucleotide for coding it |
| 05/29/2002 | CN1351152A Polypeptide-human siayltransferase (hST30-1) 12.87 and polynucleotide for coding it |
| 05/29/2002 | CN1351151A Polypeptide-human protein 9.46 containing peroxidase protein characteristic sequence fragment and polynucleotide for coding it |
| 05/29/2002 | CN1351150A Polypeptide-human respiratory chain NADH dehydrogenase 30KDa subunit 11.88 and polynucleotide for coding it |
| 05/29/2002 | CN1351149A Polypeptide-human polyketone oxidase 9.57 and polynucleotide for coding it |
| 05/29/2002 | CN1351148A Polypeptide-human cytochrome C oxidase subunit VIIa 19.25 and polynucleotide for coding it |
| 05/29/2002 | CN1351147A Polypeptide-human ribonucleotide reductase 10.45 and polynucleotide for coding it |
| 05/29/2002 | CN1351146A Polypeptide-aldehyde-ketone reductase 8.8 and polynucleotide for coding it |
| 05/29/2002 | CN1351145A Polypeptide-human dioxygenase 23.87 and polynucleotide for coding it |
| 05/29/2002 | CN1351144A Polypeptide-human uracil mononucleotide synthetase 11.27 and polynucleotide for coding it |
| 05/29/2002 | CN1351143A Polypeptide-RNA polymerase I 40KDa subunit 21.78 and polynucleotide for coding it |
| 05/29/2002 | CN1351142A Polypeptide-DNA topoisomerae II-beta (TOP 28) 9.02 and polynucleotide for coding it |
| 05/29/2002 | CN1351081A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351080A Human protein with cancer call growth suppressing function and its coding sequence |
| 05/29/2002 | CN1351079A Human protein with cancer cell growth suppressing function and its coding sequence |
| 05/29/2002 | CN1085687C Polymeric matrices and their uses in pharmaceutial compositions |
| 05/28/2002 | US6395960 A genetically engineered rodent; diagnosis and therapy for alzheimer's disease |
| 05/28/2002 | US6395891 A nucleic acid comprising of a nucleation motif and an oligomerization motif; allowing the nucleic acid molecule to bind rev protein monomers; therapy |
| 05/28/2002 | US6395888 High affinity nucleic acid ligands of complement system proteins |
| 05/28/2002 | US6395884 Purifying human alpha galactosidase from human cells by passing cells over a hydrophobic interaction resin; therapy for fabry's disease |
| 05/28/2002 | US6395883 Soluble morphogenic protein complex compositions of matter |
| 05/28/2002 | US6395882 Selectin ligands |
| 05/28/2002 | US6395880 Method for purification of antithrombin III using an anion exchanger |
| 05/28/2002 | US6395876 High-affinity tryptophan transporter |
| 05/28/2002 | US6395873 Method and composition for treating thrombosis |
| 05/28/2002 | US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment |
| 05/28/2002 | US6395770 Method and compositions for administering taxanes orally to human patients |
| 05/28/2002 | US6395763 Antitumor, anticancer agents; immunosuppressant |
| 05/28/2002 | US6395744 Administering apomorphine and androgen |
| 05/28/2002 | US6395736 Compositions and methods for the treatment of anorectal disorders |
| 05/28/2002 | US6395715 Antitumor agents |
| 05/28/2002 | US6395712 Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy |
| 05/28/2002 | US6395708 Method for preventing diarrhea |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395706 Alopecia |
| 05/28/2002 | US6395548 Methods of modulating of angiogenesis |
| 05/28/2002 | US6395545 Antisense modulation of inhibitor-kappa B kinase-alpha expression |
| 05/28/2002 | US6395541 Suppressing viral activity in virally infected cells; obtain cells, incubate with viricide, monitoring cell inhibition enzyme activity |
| 05/28/2002 | US6395530 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 05/28/2002 | US6395514 Polynucleotides encoding chemokineα-5 |
| 05/28/2002 | US6395513 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 05/28/2002 | US6395512 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 05/28/2002 | US6395510 Vertebrate apoptosis gene: compositions and methods |
| 05/28/2002 | US6395509 DNA encoding Rhesus ob protein |
| 05/28/2002 | US6395508 Peptide mixture and products thereof |
| 05/28/2002 | US6395499 Methods of identifying modulators of a DP prostaglandin receptor |
| 05/28/2002 | US6395498 Methods of identifying compounds that modulate body weight using the OB receptor |
| 05/28/2002 | US6395492 Derivatized oligonucleotides having improved uptake and other properties |
| 05/28/2002 | US6395484 Generating culture of preferential proteins; obtain cells; transform cells, recover genetically engineered cells, recover preferentially expressed polypeptides |
| 05/28/2002 | US6395476 Evaluating long term outcome of viral disease infection; obtain sample, obtain viral nucleotide sequence from sample, screen sequences for presence of mutation in preferential codon, presence of mutation indicate more sever viral disease |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395468 Human phosphatidylinositol synthase |
| 05/28/2002 | US6395310 Composition containing embryo bud and seed coat from rice and fruit body of Ganoderma lucidum for treating diabetes |
| 05/28/2002 | US6395306 For rheumatoid arthritis |
| 05/28/2002 | US6395302 Method for the preparation of microspheres which contain colloidal systems |